Puxitatug Samrotecan (P-Sam, AZD8205)
NCT07162480
AstraZeneca · Phase 2 · Recruiting · Enrollment 28
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
Puxitatug Samrotecan (P-Sam, AZD8205)
AstraZeneca · Phase 2 · Recruiting · Enrollment 28
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.